So Y. Oh

Yangsan, KR 
Yangsan, KR 

Overview

So Oh practices practicing medicine in Yangsan, Republic of Korea.

Her clinical expertise encompasses Acute Pain, Agranulocytosis, PIK3CA-Related Overgrowth Spectrum, and Venous Thromboembolism (VTE).

She is actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Yangsan, Republic of Korea
Other Locations
Seoul, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
Enrollment Status: Terminated
Publish Date: February 19, 2026
Intervention Type: Drug, Radiation
Study Phase: Phase 3
Public-interest Multicenter Umbrella Trial Based on Genetic Analysis in Korean Head and Neck Cancer and Esophageal Cancer Patient - Part 1 (HNSCC)]
Public-interest Multicenter Umbrella Trial Based on Genetic Analysis in Korean Head and Neck Cancer and Esophageal Cancer Patient - Part 1 (HNSCC)]
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Drug
Study Drugs: BYL719, Poziotinib, Nintedanib, Abemaciclib, Durvalumab, Tremelimumab
Study Phase: Phase 2
Comparison of Safety, Efficacy, and Patient-perceived Satisfaction Between Initial Routine Peripherally Inserted Central Catheters Insertion and General Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study
Comparison of Safety, Efficacy, and Patient-perceived Satisfaction Between Initial Routine Peripherally Inserted Central Catheters Insertion and General Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study
Enrollment Status: Completed
Publish Date: August 25, 2020
Intervention Type: Device
Study Phase: Phase 2
View 2 Less Clinical Trials

34 Total Publications

WITHDRAWN:A Prospective Study of Non‑Treating Medical Institution Use for Supportive Care During Adjuvant Chemotherapy After Curative Surgery (PRO-SUCCESS).
WITHDRAWN:A Prospective Study of Non‑Treating Medical Institution Use for Supportive Care During Adjuvant Chemotherapy After Curative Surgery (PRO-SUCCESS).
Journal: Cancer research and treatment
Published: November 01, 2025

Frequently Asked Questions about So Y. Oh

Is So Y. Oh a top-rated expert for Acute Pain?

MediFind is an objective health platform that identifies experts based on real-world data. So Y. Oh is classified as an Experienced expert for Acute Pain, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does So Y. Oh participate in research or clinical trials?

Yes. So Y. Oh has published 34 articles and abstracts on conditions like Acute Pain. You can view a list of So Y. Oh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Oh's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile